Benzyl 2,5-diazaspiro[3.4]octane-5-carboxylate
≥95%
- Product Code: 83220
CAS:
1160248-45-2
| Molecular Weight: | 246.31 g./mol | Molecular Formula: | C₁₄H₁₈N₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD12198812 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature, dry, sealed |
Product Description:
This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of biologically active molecules. Its unique spirocyclic structure makes it valuable for designing inhibitors targeting specific enzymes or receptors, particularly in the development of central nervous system (CNS) drugs. Researchers leverage its framework to enhance binding affinity and selectivity in drug candidates. Additionally, it is employed in the preparation of novel compounds for studying neurological disorders, such as Parkinson's disease and depression, due to its potential to modulate neurotransmitter systems. Its application extends to medicinal chemistry, where it aids in the exploration of new therapeutic agents with improved pharmacokinetic properties.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿30,420.00 |
+
-
|
Benzyl 2,5-diazaspiro[3.4]octane-5-carboxylate
This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of biologically active molecules. Its unique spirocyclic structure makes it valuable for designing inhibitors targeting specific enzymes or receptors, particularly in the development of central nervous system (CNS) drugs. Researchers leverage its framework to enhance binding affinity and selectivity in drug candidates. Additionally, it is employed in the preparation of novel compounds for studying neurological disorders, such as Parkinson's disease and depression, due to its potential to modulate neurotransmitter systems. Its application extends to medicinal chemistry, where it aids in the exploration of new therapeutic agents with improved pharmacokinetic properties.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :